$CGON Balance Sheet | Understand Stock

$CGON

$62.94 +$1.38 (2.24%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024
Assets
Current assets:
Cash and cash equivalents
Marketable securities
Inventory
Accounts receivable, net
Prepaid expenses and other current assets
Accounts receivable - other
Total current assets
Property and equipment, net
Note receivable, net
Operating lease right-of-use assets
Intangible assets, net
Goodwill
Other assets
Deferred offering costs
Total assets
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
Success fee liability, current portion
Operating lease liabilities, current portion
Accrued expenses and other current liabilities
Total current liabilities
Success fee liability, non-current
Long-term debt
Operating lease liabilities, net of current portion
Deferred tax liability
Other liabilities
Total liabilities
Redeemable convertible preferred stock:
Redeemable convertible preferred stock
Stockholders' equity:
Common stock, $0.0001 par value per share; 700,000,000 and 700,000,000 share authorized as of June 30, 2026 and December 31, 2025, respectively; 88,306,390 and 80,689,128 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Comments